Related Experiment Video
Updated: Mar 2, 2026
03:42
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
2.1K
HNF1α defect influences post-prandial lipid regulation
Matthieu St-Jean1, François Boudreau2, André C Carpentier1
1Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada.
Plos One
|May 12, 2017
Summary
Hepatocyte nuclear factor 1 alpha (HNF1α) defects, causing MODY3 diabetes, lead to lower insulin secretion but improved insulin sensitivity and lipid profiles compared to type 2 diabetes. This study reveals unique metabolic responses in MODY3 patients after a meal.
Area of Science:
- Endocrinology and Metabolism
- Genetics of Diabetes
- Nutritional Physiology
Background:
- Hepatocyte nuclear factor 1 alpha (HNF1α) gene defects are the primary cause of Mature Onset Diabetes of the Young type 3 (MODY3).
- HNF1α plays a crucial role in beta-cell function and insulin secretion, but also influences other metabolic pathways relevant to diabetes.
- Understanding the broader metabolic impact of HNF1α defects beyond insulin secretion is essential for comprehensive diabetes management.
Purpose of the Study:
- To investigate and compare postprandial gut hormone, lipid, and insulin regulation in individuals with HNF1α defects (MODY3) versus non-diabetic controls and type 2 diabetes (T2D) patients.
- To elucidate the metabolic phenotype associated with MODY3, focusing on responses to a standardized meal challenge.
- To assess the role of HNF1α in broader metabolic pathways, including lipid metabolism and insulin sensitivity.
Main Methods:
- A standardized liquid meal was administered to participants in the MODY3, control, and T2D groups.
- Postprandial measurements over six hours included blood glucose, c-peptide, insulin, gut hormones (ghrelin, GIP, GLP-1), and lipids (NEFA, triglycerides).
- Insulin secretion indices and insulin sensitivity (Matsuda index) were calculated.
Main Results:
- MODY3 participants exhibited lower insulin secretion indices, confirming the known beta-cell defect, yet displayed similar HbA1c levels to T2D patients.
- MODY3 patients demonstrated significantly greater insulin sensitivity (Matsuda index) compared to T2D patients.
- Early post-prandial non-esterified fatty acid (NEFA) reduction was more pronounced in MODY3, despite lower initial insulin secretion, and triglyceride levels remained lower than in T2D.
Conclusions:
- Individuals with MODY3 show a distinct metabolic profile characterized by enhanced early post-prandial NEFA reduction and maintained low triglyceride levels, even with impaired insulin secretion.
- The findings suggest that HNF1α defects influence lipid metabolism and insulin sensitivity in ways that differentiate MODY3 from T2D.
- These results highlight the complex role of HNF1α in metabolic regulation beyond its impact on beta-cell function.
